Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy

Completed · Phase 4

Conditions studied: Peripheral Neuropathy, Antineoplastic Combined Chemotherapy Protocols

In brief

This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to chemotherapy-induced neuropathic pain in patients with cancer.

Key facts

Study ID

NCT00380965

Run by

NEMA Research, Inc.

People needed

23

Starts

2006-10-01

Expected to finish

2007-10-01

Last updated by the study team

2008-02-15

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with chemotherapy-induced neuropathic pain.
• Chronic daily pain present for at least 2 months.
• On stable analgesic regimen for one month.
• Baseline pain score greater than 40mm on a VAS.

You may not qualify if…

• Hypersensitivity to compounds in study drug or similar drugs
• Pregnant or lactating females
• Drug or alcohol abuse
• Unstable medical condition

Where it is running

• South Florida Medical Research — Aventura, Florida, United States
• Naples Anesthesia and Pain Associates — Naples, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.